Summary
The agonistic potencies of (±)muscarine, (±)cis - 2 - methyl - 5 - [(dimethylamino)methyl] - 1,3 -oxathiolane methiodide (cis-oxathiolane) and its two enantiomers were determined at muscarinic M1 and M2 receptors in the pithed rat. In non-pretreated animals, i.v. administration of these agents produced bradycardic effects mediated by cardiac M2 receptors followed by increases in heart rate mediated by M1 receptors in sympathetic ganglia. As these responses have been shown to partly overlap, “true” M1 and M2 potencies were determined after selective blockade of M1 and M2 receptors by pirenzepine and methoctramine, respectively. A similar rank order of agonist potencies was obtained at M1 and M2 receptors: (+)cis-oxathiolane > (±)cis-oxathiolane > (±)muscarine > (-)cis-oxathiolane. At both receptor subtypes, (+)cis-oxathiolane was considerably more potent (ca. 30-fold) than its corresponding (−) enantiomer indicating that the agonist binding sites of the two receptor subtypes may have similar stereochemical properties. While (±)muscarine showed similar potencies at M1 and M2 receptors, racemic cis-oxathiolane and its two enantiomers showed a slight selectivity (3–7 fold) for M1 receptors indicating the potential usefulness of these compounds in the development of selective M1 receptor agonists.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Angeli P, Brasili L, Giannella MT, Gualtieri F, Picchio MT, Teodori E (1988) Chiral muscarinic agonists possessing a 1,3-oxathiolane nucleus: enantio- and tissue-selectivity on isolated preparations of guinea-pig ileum and atria and of rat urinary bladder. Naunyn-Schmiedeberg's Arch Pharmacol 337:241–245
Bonner TI (1989) Identification of a family of muscarinic acetylcholine receptor genes. Trends Neurosci 12:148–151
de Jonge A, Doods HN, Riezebos J, van Zwieten PA (1986) Heterogeneity of muscarinic binding sites in rat brain, submandibular gland and atrium. Br J Pharmacol 89:551P
Doods HN, Mathy MJ, Davidesko D, van Charldorp KJ, de Jonge A, Van Zwieten PA (1987) Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. J Pharmacol Exp Ther 242:257–262
Giachetti A, Micheletti R, Montagna E (1986) Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist. Life Sci 38:1663–1672
Hammer R, Giachetti A (1982) Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci 31:2991–2998
Hammer R, Berrie CP, Birdsall NJM, Burgen ASV, Hulme EC (1980) Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283:90–94
Lambrecht G, Feifel R, Wagner-Röder M, Strohmann C, Zilch H, Tacke R, Waelbroeck M, Christophe J, Boddeke H, Mutschler E (1989) Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Eur J Pharmacol 168:71–80
Melchiorre C (1988) Polymethylene tetramines: a new generation of selective muscarinic antagonists. Trends Pharmacol Sci 9: 216–220
Melchiorre C, Cassinelli A, Quaglia W (1987a) Differential blockade of muscarinic receptor subtypes by polymethylene tetra-amines. Novel class of selective antagonists of cardiac M2 muscarinic receptors. J Med Chem 30:201–204
Melchiorre C, Angeli P, Lambrecht G, Mutschler E, Picchio MT, Wess J (1987b) Antimuscarinic action of methoctramine, a new cardioselective M2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine. Eur J Pharmacol 144:117–124
Micheletti R, Montagna E, Giachetti A (1987) AF-DX 116, a cardioselective muscarinic antagonist. J Pharmacol Exp Ther 241:628–634
Mutschler E, Moser U, Wess J, Lambrecht G (1988) New approaches to the subclassification of muscarinic receptors. In: Melchiorre C, Giannella M (eds) Recent advances in receptor chemistry. Elsevier, Amsterdam, pp 195–217
Shipley RE, Tilden JH (1947) A pithed rat preparation suitable for assaying pressor substances. Proc Soc Exp Biol Med 64:453–455
Teodori E, Gualtieri F, Angeli P, Brasili L, Giannella M, Pigini M (1986) Resolution, absolute configuration, and cholinergic enantioselectivity of (+)- and (−)-cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodide. J Med Chem 29:1610–1615
van Charldorp KJ, de Jonge A, Thoolen MJMC, van Zwieten PA (1985) Subclassification of muscarinic receptors in the heart, urinary bladder and sympathetic ganglia in the pithed rat. Naunyn-Schmiedeberg's Arch Pharmacol 331: 301–306
Wess J, Lambrecht G, Moser U, Mutschler E (1987) Stimulation of ganglionic muscarinic M1 receptors by a series of tertiary arecaidine and isoarecaidine esters in the pithed rat. Eur J Pharmacol 134:61–67
Wess J, Angeli P, Melchiorre C, Moser U, Mutschler E, Lambrecht G (1988) Methoctramine selectivity blocks cardiac muscarinic M2 receptors in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 338:246–249
Wilffert B, Davidesko D, de Jonge A, Thoolen MJMC, Timmermans PBMWM, van Zwieten PA (1983) Role of ganglionic M1 and M2 receptors in the neuronal control of the cardiovascular system of the normotensive rat as determined with pilocarpine. Eur J Pharmacol 95:109–116
Author information
Authors and Affiliations
Additional information
Send offprint requests to F. Cantalamessa at the above address
Rights and permissions
About this article
Cite this article
Angeli, P., Brasili, L., Cantalamessa, F. et al. Determination of muscarinic agonist potencies at M1 and M2 muscarinic receptors in a modified pithed rat preparation. Naunyn-Schmiedeberg's Arch Pharmacol 342, 625–629 (1990). https://doi.org/10.1007/BF00175704
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00175704